Ontology highlight
ABSTRACT:
SUBMITTER: Saarenheimo J
PROVIDER: S-EPMC6411700 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
Saarenheimo Jatta J Eigeliene Natalja N Andersen Heidi H Tiirola Marja M Jekunen Antti A
Frontiers in oncology 20190305
Targeted therapies have allowed for an individualized treatment approach in non-small-cell lung cancer (NSCLC). The initial therapeutic decisions and success of targeted therapy depend on genetic identification of personal tumor profiles. Tissue biopsy is the gold standard for molecular analysis, but non-invasive or minimally invasive liquid biopsy methods are also now used in clinical practice, allowing for later monitoring and optimization of the cancer treatment. The inclusion of liquid biops ...[more]